ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO138

The Nicotinic Acid Receptor HCA2 Regulates Progression of AKI and Development of CKD in Mouse Models of Sepsis and Postischemic Kidney Injury

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Zandi-Nejad, Kambiz, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
  • Parikh, Samir M., The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Takakura, Ayumi, Brigham and Women's Hospital, Boston, Massachusetts, United States
Background

Patients with sepsis-associated AKI (SA-AKI) have longer ICU stay compared to patients with sepsis alone, higher mortality rate and higher requirement for renal replacement therapy. SA-AKI is also a risk factor for development and progression of CKD. However, pathophysiological mechanisms of SA-AKI remain poorly understood. We have previously shown that hydrocarboxylic acid receptor 2 (HCA2) is expressed in SA-AKI kidneys and in activated macrophages and that Hca2 KO male mice have higher mortality than wild type mice in response to low-grade cecal ligation and puncture-induced sepsis (CLP-IS). We have also shown that renal tubular cell expression of the mitochondrial biogenesis factor PGC1α increases the local abundance of HCA2 ligand beta-hydroxybutyrate (β-OH B) and protects mice from experimental AKI. Thus, we hypothesized that activation of HCA2 may have a protective role in SA-AKI.

Methods

We used well-established models CLP (generate sepsis and SA-AKI), and ischemia reperfusion (IR).

Results

Here we show 100% of female Hca2 KO mice died within 3 days after severe CLP whereas 77% of WT female mice were alive at 3 days after surgery and nearly 40% of the female WT mice were alive at 2 weeks. Conversely, activation of HCA2 by nicotinic acid or β-OH B improved survival in both male and female mice after severe CLP-IS by more than 40%. Deficiency of Hca2 resulted in greater kidney interstitial fibrosis and pro-inflammatory cytokine production such as TNF-α after CLP-induced sepsis. Renal tubule specific overexpression of PGC1α (Pax8rtTA; tetO-PGC1α) improved survival and renal function during sepsis. However, deficiency of Hca2 abolished the reno-protective effects of PGC1α during SA-AKI, suggesting that HCA2 may be required for PGC1α-induced renoprotection. Finally, we further investigated the role of HCA2 on AKI-to-CKD transition. In bilateral IR (a model of AKI) and in unilateral IR (a model of CKD), Hca2-/- mice exhibited greater renal damage (assessed by pathology and BUN) and increased pro-inflammatory cytokine production compared with wild-type mice.

Conclusion

Considered together, we propose that a positive feedback loop of HCA2 activation through PGC1α signaling may thwart maladaptive repair, thereby delaying or inhibiting transition from AKI to CKD.

Funding

  • Private Foundation Support